(Liraglutide) Novo Nordisk
1 Introduction Polycystic ovary syndrome (PCOS) represents one of the most complex endocrine-metabolic disorders affecting women of reproductive age, characterized by a collection of reproductive, metabolic, and psychological manifestations ( Beyond the classic triad of hyperandrogenism (HA), ovulatory dysfunction, and polycystic ovarian morphology, PCOS extends into domains of insulin resistance, dyslipidemia, chronic inflammation, and heightened oxidative stress (OS) ( Conventional therapeutic strategies, though effective in symptom control, remain largely palliative, targeting isolated components of this multifactorial syndrome ( Thus, this review critically examines the triadic potential of these agents, not as standalone supplements but as a synergistic bioactive cocktail targeting the redox-endocrine axis
Hormonal Balance: Weight loss achieved through Semaglutide can lead to better hormonal regulation, particularly in hormones like estrogen that are linked to breast cancer risk
The bidirectional relationship between T2DM and depression is formed due to their common pathophysiological mechanisms
Since we are not able to exploit the full benefit of GLP-1 and its analogs with current drug delivery systems [79], further research will be essential to fully elucidate the mechanism and/or site(s) of action of GLP-1 and its analogs, enabling next-generation therapeutics for type 2 diabetes
The IV method ensures that the antioxidant is absorbed directly into the bloodstream, giving faster and more visible results compared to oral capsules or topical creams